Back
Monopar Therapeutics, Inc. 10K Form
Sell
48
MNPR
Monopar Therapeutics, Inc.
Last Price:
$80.49
Seasonality Move:
52.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MNPR News And Ratings
See the #1 stock for the next 7 days that we like better than MNPR
MNPR Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $21.25 |
| Price / Book: | 3.79 |
Profitability
| EPS (TTM): | -3.43890 |
|---|---|
| Net Income (TTM): | $-19.4M |
| Gross Margin: | $0 |
| Return on Equity: | -31.63% |
| Return on Assets: | -30.42% |
Monopar Therapeutics, Inc. Earnings Forecast
Key Monopar Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 10 years have been positive in 2 years.
Monopar Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MNPR |
| Website: | monopartx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 56.1 |
| Quick Ratio: | 55.94 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MNPR Technical Analysis vs Fundamental Analysis
Sell
48
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy or a Sell?
-
Monopar Therapeutics, Inc. stock is rated a SellThe current Monopar Therapeutics, Inc. [MNPR] share price is $80.38. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.